The DOI matches its Crossref record; 231 of the 233 references it cites were found in a registry or an index.
Synaptic degeneration in Alzheimer's disease
Abstract
Synaptic loss is the major neurobiological substrate of cognitive dysfunction in Alzheimer's disease (AD). Synaptic failure is an early event in the pathogenesis that is clearly detectable already in patients with mild cognitive impairment (MCI), a prodromal state of AD. It progresses during the course of AD and in most early stages involves mechanisms of compensation before reaching a stage of decompensated function. This dynamic process from an initially reversible functionally responsive stage of down-regulation of synaptic function to stages irreversibly associated with degeneration might be related to a disturbance of structural brain self-organization and involves morpho-regulatory molecules such as the amyloid precursor protein. Further, recent evidence suggests a role for diffusible oligomers of amyloid beta in synaptic dysfunction. To form synaptic connections and to continuously re-shape them in a process of ongoing structural adaptation, neurons must permanently withdraw from the cell cycle. Previously, we formulated the hypothesis that differentiated neurons after having withdrawn from the cell cycle are able to use molecular mechanisms primarily developed to control proliferation alternatively to control synaptic plasticity. The existence of these alternative effector pathways within neurons might put them at risk of erroneously converting signals derived from plastic synaptic changes into the program of cell cycle activation, which subsequently leads to cell death. The molecular mechanisms involved in cell cycle activation might, thus, link aberrant synaptic changes to cell death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Synaptic loss is frequently cited as the best neuropathological correlate of dementia severity in AD (Terry, et al., 1991) and has been linked to the accumulation of both amyloid-β and tau pathology (Arendt, 2009).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Arendt, 2009
In the citing paper
“Detailed analysis of postmortem tissue has revealed synapse loss in mild cognitive impairment (MCI), but an even greater loss in Alzheimer’s disease, indicating that synapse loss occurs early in the progression of Alzheimer’s disease and worsens as the disease advances21.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [21]
In the citing paper
“Individuals with Alzheimer’s disease demonstrate altered expression of many synaptic proteins21.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [21]
In the citing paper
“Synapses have long been viewed as critical sites of AD pathology [6, 28, 112, 119, 168] and diverse evidence had supported that synapses are major sites of Aβ pathology and also generation.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [6]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“fibrillary degeneration as outlined in the Braaks’ staging [24].”
BackgroundSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“There is evidence that soluble oligomers of Ab can selectively impair synaptic plasticity mechanisms necessary for memory processing [35, 71, 176].”
BackgroundGoate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“It had not been analyzed previously, however, whether this synaptotrophic effect is maintained in mutated forms of APP that show linkage to familial forms of AD (FAD) and thus have been identified as one potential cause of the disease [64].”
BackgroundAmyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · cited 1×
“extensively, and numerous studies have focused on elevations in the Ab-peptide, which is generated during normal metabolism of APP [70] and forms the major component of plaques, a major hallmark of the disease [142].”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 4×
“Data obtained by electron microscopy [40, 42–44, 182– 184], immunocytochemical and biochemical analyses on synaptic marker proteins in AD biopsies and autopsies [47, 59, 83, 140, 211] indicate that synaptic loss in the hippocampus and neocortex is an early event [81, 135] and the major structural correlate of cognitiv…”
BackgroundResultInfluentialWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“Both cell-derived and synthetic soluble Ab oligomers can disrupt hippocampal long-term potentiation in slices and in vivo, and can also impair the memory of complex learned behavior in rodents and decrease dendritic spine density in organotypic hippocampal slice cultures [48, 98, 99, 104, 156, 190, 192, 222].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 1×
“Both cell-derived and synthetic soluble Ab oligomers can disrupt hippocampal long-term potentiation in slices and in vivo, and can also impair the memory of complex learned behavior in rodents and decrease dendritic spine density in organotypic hippocampal slice cultures [48, 98, 99, 104, 156, 190, 192, 222].”
BackgroundDegeneration and Regeneration of the Nervous System.
(1929) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1929.02710220063037 · Cited by 2,908
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 2×
“Dynamic synaptic reorganization during the process of degeneration is further supported by observations of an increase in synaptic size that accompanies synaptic loss in various cortical regions in AD and might reflect the attempt of a functional compensatory increase of synaptic efficacy [18, 44, 182].”
Background
Research works printed but not linked: 11
- Brunelli MP, Kowall NW, Lee JM, McKee AC (1991) Synaptophysin immunoreactivity is depleted in cortical laminae with dense dystrophic neurites and neurofibrillary tangles. J Neuropathol Exp Neurol 50:315
- Duval M (1895) Hypothèses sur la physiologie des centres nerveux; théorie histologique du sommeil. Comptes Rendus Hebdomadaires des Séances et Mémoires de la Société de Biologie 47:74–77
- Duval M (1900) Les neurones. L’amiboïsme nerveux la théorie histologique du sommeil. Revue de l’Ècole d’Anthropologie de Paris 10:37–71
- Hut RA, de Wilde MC, Strijkstra AM, Van der Zee EA, Daan S (2001) Neuronal changes in the hippocampus and SCN of hibernating ground squirrels. Soc Neurosci Abstr 27:535.11
- Lépine MR (1895) Théorie mécanique de la paralysie hystérique, du somnambulisme, du sommeil naturel et de la distraction. Soc Biol 5:85–86
- Lugaro E (1895) Sulle Modificazioni delle cellule nervose. Lo Sperimentale 49:159–193
- Lugaro E (1899) I recenti progressi dell’anatomia del sistema nervoso in rapporto alla psicologia ed alla psichiatria. Rivista di Patologia Nervosa e Mentale 4:481–514
- Lugaro E (1900) I recenti progressi dell’anatomia del sistema nervoso in rapporto alla psicologia ed alla psichiatria. Rivista Sperimentale di Freniatria e Medicina Legale delle Alienazioni Mentali 26:831–894
- Masliah E, Terry R (1994) The role of synaptic pathology in the mechanisms of dementia in Alzheimer’s disease. Clin Neurosci 1:192–198
- Ramón y Cajal S (1911) Histologie du systeme nerveux. A. Maloine. Paris. (This is the second edition, in French, of the Textura del sistema nervioso del hombre y los vertebrados of 1899. Quotations here are from the English translation by N. and L. Swanson, vol 1. Oxford University Press 1995, New York
- Tanzi E (1893) I fatti e le induzioni nell’odierna istologia del sistema nervoso. Rivista Sperimentale di Frenetria e Medicina Legale della Alienzioni mentali 19:419–472
Cited by
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
“Detailed analysis of postmortem tissue has revealed synapse loss in mild cognitive impairment (MCI), but an even greater loss in Alzheimer's disease, indicating that synapse loss occurs early in the progression of Alzheimer's disease and worsens as the disease advance”
BackgroundOxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T., & Surmeier, D. J. (2010) · Nature · doi:10.1038/nature09536 · Cited by 843
The case for rejecting the amyloid cascade hypothesis
Herrup, K. (2015) · Nature Neuroscience · doi:10.1038/nn.4017 · Cited by 768
Castellani, R. J., Rolston, R. K., & Smith, M. A. (2010) · Disease-a-Month · doi:10.1016/j.disamonth.2010.06.001 · Cited by 519
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
D'Amelio, M., Cavallucci, V., Middei, S., Marchetti, C., Pacioni, S., Ferri, A., Diamantini, A., De Zio, D., Carrara, P., Battistini, L., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2709 · Cited by 572
“2709" language="eng" relation="no"> Episodic hippocampal-dependent memory loss, the earliest clinical sign of Alzheimer's disease, is thought to be a result of changes in synaptic function rather than neuronal los”
Background
Metadata
- Authors
- Arendt, T.
- Affiliations
- Leipzig University (DE)
- Corresponding author
- Arendt, Thomas
- ORCID
- Arendt, Thomas
- Venue
- Acta Neuropathologica
- Published
- 2009-04-24
- Volume
- 118
- Issue
- 1
- Pages
- 167-179
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2147435466
- Cited by
- 517
- References
- 233
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 21 · 2023: 28 · 2022: 39 · 2021: 47 · 2020: 32 · 2019: 28 · 2018: 31 · 2017: 28 · 2016: 35 · 2015: 19 · 2014: 32 · 2013: 44 · 2012: 29
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- synaptic degeneration, Alzheimer's disease, synaptic loss, mild cognitive impairment, cognitive impairment, synaptic plasticity, amyloid precursor protein, amyloid-beta oligomers, neuronal cell death
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cell Cycle, Cognition Disorders, Humans, Nerve Degeneration, Neuronal Plasticity, Neurons, Phosphorylation, Receptors, Cell Surface, Synapses, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, tau Proteins, Protease Nexins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synaptic degeneration in Alzheimer's disease. https://app.cochat.ai/papers/10.1007/s00401-009-0536-x
- The paper
- Arendt, T. (2009). Synaptic degeneration in Alzheimer's disease. Acta Neuropathologica. https://doi.org/10.1007/s00401-009-0536-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.